Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$4.96bnn/an/a
au flag iconMSBMesoblastAU$2.90bnn/an/a
au flag iconPYCPYC TherapeuticsAU$1.19bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$1.16bnn/an/a
au flag iconRACRacura OncologyAU$565.96mn/an/a
au flag iconCGSCogstateAU$428.89m29.10.74%
au flag iconTTXTetratherixAU$247.63mn/an/a
au flag iconDXBDimerixAU$237.16mn/an/a
au flag iconBXNBioxyneAU$153.55m17.88n/a
au flag iconNYRNyradaAU$142.31mn/an/a
au flag iconACWActinogen MedicalAU$127.48mn/an/a
au flag iconATHAlterity TherapeuticsAU$108.75mn/an/a
au flag iconIMMImmutepAU$101.69mn/an/a
au flag iconALAArovella TherapeuticsAU$97.30mn/an/a
au flag iconILAIsland PharmaceuticalsAU$96.86mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$96.42mn/an/a
au flag iconCYPCynata TherapeuticsAU$85.48mn/an/a
au flag iconATXAmplia TherapeuticsAU$84.66mn/an/a
au flag iconLTPLtr PharmaAU$72.66mn/an/a
au flag iconRHYRhythm BiosciencesAU$64.03mn/an/a